Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation

Mol Cell. 2007 Oct 26;28(2):200-13. doi: 10.1016/j.molcel.2007.08.021.

Abstract

During muscle regeneration, the mechanism integrating environmental cues at the chromatin of muscle progenitors is unknown. We show that inflammation-activated MKK6-p38 and insulin growth factor 1 (IGF1)-induced PI3K/AKT pathways converge on the chromatin of muscle genes to target distinct components of the muscle transcriptosome. p38 alpha/beta kinases recruit the SWI/SNF chromatin-remodeling complex; AKT1 and 2 promote the association of MyoD with p300 and PCAF acetyltransferases, via direct phosphorylation of p300. Pharmacological or genetic interference with either pathway led to partial assembly of discrete chromatin-bound complexes, which reflected two reversible and distinct cellular phenotypes. Remarkably, PI3K/AKT blockade was permissive for chromatin recruitment of MEF2-SWI/SNF complex, whose remodeling activity was compromised in the absence of MyoD and acetyltransferases. The functional interdependence between p38 and IGF1/PI3K/AKT pathways was further established by the evidence that blockade of AKT chromatin targets was sufficient to prevent the activation of the myogenic program triggered by deliberate activation of p38 signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Animals
  • Cell Line
  • Cell Shape
  • Chromatin / metabolism*
  • Chromones / pharmacology
  • E1A-Associated p300 Protein / metabolism
  • Gene Expression Regulation, Developmental
  • Imidazoles / pharmacology
  • Insulin-Like Growth Factor I / genetics
  • Insulin-Like Growth Factor I / metabolism*
  • MAP Kinase Kinase 6 / genetics
  • MAP Kinase Kinase 6 / metabolism*
  • Mice
  • Morpholines / pharmacology
  • Muscle Development* / drug effects
  • Muscle Development* / genetics
  • MyoD Protein / metabolism
  • Myoblasts / drug effects
  • Myoblasts / enzymology
  • Myoblasts / metabolism*
  • Myogenic Regulatory Factors / metabolism
  • Phenotype
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism*
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Promoter Regions, Genetic
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Pyridines / pharmacology
  • RNA Interference
  • RNA, Small Interfering / metabolism
  • Signal Transduction* / drug effects
  • Signal Transduction* / genetics
  • Transcription, Genetic
  • Transfection
  • p300-CBP Transcription Factors / metabolism
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / genetics
  • p38 Mitogen-Activated Protein Kinases / metabolism*

Substances

  • Chromatin
  • Chromones
  • Imidazoles
  • Morpholines
  • MyoD Protein
  • MyoD1 myogenic differentiation protein
  • Myogenic Regulatory Factors
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Pyridines
  • RNA, Small Interfering
  • insulin-like growth factor-1, mouse
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • Insulin-Like Growth Factor I
  • E1A-Associated p300 Protein
  • Ep300 protein, mouse
  • p300-CBP Transcription Factors
  • p300-CBP-associated factor
  • Akt1 protein, mouse
  • Akt2 protein, mouse
  • Proto-Oncogene Proteins c-akt
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase 6
  • Map2k6 protein, mouse
  • SB 203580